Señales en vivo de OLMA | Maximiza tus Ganancias con Getagraph.com

COMPRAR 108859 min ago

@ $15.41

Emitido: 14 feb 2024 @ 11:19

Retorno: -34.07%

Señal anterior: feb 14 - 09:30

Señal anterior: Vender

Retorno: -3.51 %

Live Chart Being Loaded With Signals

Commentary (29 abr 2024 @ 16:00):

Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers...

Stats
Volumen de hoy	332 566
Volumen promedio	831 451
Capitalización de mercado	568.09M
EPS	$0 ( 2024-03-14 )
Próxima fecha de ganancias	( $-0.530 ) 2024-05-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.75
ATR14	$0.0190 (0.19%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-28	Harmon Cyrus	Sell	20 000	Common Stock
2024-03-18	Zojwalla Naseem	Sell	13 700	Stock Option (Right to Buy)
2024-03-18	Zojwalla Naseem	Buy	13 700	Common Stock
2024-03-05	Rappaport Andrew	Buy	385 965	Common Stock
2024-03-05	Rappaport Andrew	Sell	481 014	Common Stock

INSIDER POWER
66.24
Last 96 transactions
Buy: 6 282 820 \| Sell: 988 788

Volumen Correlación

Largo: -0.06 (neutral)

Corto: -0.46 (neutral)

Signal:(72.527) Neutral

Olema Pharmaceuticals, Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Olema Pharmaceuticals, Correlación - Moneda/Commodity

-0.79
( moderate negative )

-0.86
( strong negative )

0.00
( neutral )

-0.82
( strong negative )

-0.26
( neutral )

0.48
( neutral )

Olema Pharmaceuticals, Finanzas

Annual	2023
Ingresos:	$0
Beneficio Bruto:	$-377 000 (0.00 %)
EPS:	$-2.14

FY	2023
Ingresos:	$0
Beneficio Bruto:	$-377 000 (0.00 %)
EPS:	$-2.14

FY	2022
Ingresos:	$0
Beneficio Bruto:	$-1.66M (0.00 %)
EPS:	$-2.56

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-1.795

Financial Reports:

No articles found.

Olema Pharmaceuticals,

Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.